Humira sales are falling, but AbbVie has successors

Humira sales are falling, but AbbVie has successors

Humira, the injectable rheumatoid arthritis treatment is pictured in a pharmacy in Cambridge, Massachusetts. JB Reed | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Sales of AbbVie‘s Humira are plummeting as the once-top-selling drug fights competition from cheaper … Read more

CVS Health (CVS) earnings Q1 2024

CVS Health (CVS) earnings Q1 2024

A person walks by a CVS Pharmacy store in Manhattan, New York, on Nov. 15, 2021. Andrew Kelly | Reuters CVS Health on Wednesday reported first-quarter revenue and adjusted earnings that missed expectations and slashed its full-year profit outlook, citing higher medical costs that are dogging the U.S. insurance industry. Shares of the company dropped … Read more

Pfizer (PFE) earnings Q1 2024

Pfizer (PFE) earnings Q1 2024

Jakub Porzycki | Nurphoto | Getty Images Pfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year profit outlook, benefitting from its broad cost-cutting program and strong sales of its non-Covid products. The company now expects to book adjusted earnings of $2.15 to $2.35 per share for the fiscal year, up from … Read more

Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.

Johnson & Johnson will pay .5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.

Johnson & Johnson on Wednesday said it will pay $6.5 billion to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer. The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.  More CNBC health coverage It … Read more

FTC challenges patents held by drugmakers, including for Ozempic

FTC challenges patents held by drugmakers, including for Ozempic

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023.  Lee Smith | Reuters The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged “junk” patents held by pharmaceutical companies for 20 brand-name drugs, including Novo Nordisk’s blockbuster diabetes drugs Ozempic, Saxenda and Victoza. … Read more

Walmart to shutter health centers, virtual care service

Walmart to shutter health centers, virtual care service

Walmart on Tuesday said it will close all of its health-care clinics across the country, a stunning reversal of its plans to bring its low-priced reputation to the dentist and doctor’s office along with the grocery aisle.  The big-box retailer said it would also shutter its telehealth provider, which it acquired for an undisclosed amount … Read more

Eli Lilly (LLY) earnings Q1 2024

Eli Lilly (LLY) earnings Q1 2024

Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020.  Mike Blake | Reuters Eli Lilly on Tuesday reported first-quarter adjusted profit that topped Wall Street’s expectations and hiked its full-year guidance on strong sales of its blockbuster diabetes drug Mounjaro and newly launched weight loss … Read more

J&J, Bristol Myers Squibb lose Medicare drug price talks challenges

J&J, Bristol Myers Squibb lose Medicare drug price talks challenges

Jonathan Raa | Nurphoto | Getty Images A federal judge in New Jersey on Monday rejected Johnson & Johnson and Bristol Myers Squibb‘s legal challenges to the Biden administration’s Medicare drug price negotiations, ruling that the program is constitutional.  The decision is another win for the Biden administration in a bitter legal fight with several … Read more

CVS Omnicare pharmacy in Vegas is first to join new pharmacy union

CVS Omnicare pharmacy in Vegas is first to join new pharmacy union

The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada on February 7, 2024. Patrick T. Fallon | AFP | Getty Images A CVS in Las Vegas has become the first location to join a new national pharmacy union, a milestone as organizers try to help … Read more

FDA approves Pfizer gene therapy Beqvez for treatment of hemophilia B

FDA approves Pfizer gene therapy Beqvez for treatment of hemophilia B

Pavlo Gonchar | Lightrocket | Getty Images The Food and Drug Administration on Friday approved Pfizer‘s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S.  The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B … Read more